APOTHEEK PYLYSER SOFIE
ActiveAPOTHEEK PYLYSER SOFIE has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €85k and a net result of €58k. Equity is growing by ~31.2% per year across the filed fiscal years. Its solvency ranks better than 38% of 10230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
78
/ 100
Excellent▼ -16 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency49▼-45
Growth78=
Stability100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.35 against 1.97 in 2024), and 73.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
26.9%
Return on assets
18.5%
Age of the figures
8 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
1 d early
2024
2 d early
2023
14 d early
2022
7 d early
2021
5 d early
2020
22 d early
2019
8 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
13-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€85k▼ 42.2%
2024 · €146k
2018: €-13k
2019: €14k
2020: €44k
2021: €66k
2022: €73k
2023: €96k
2024: €146k
2018 → 2025
Total assets
€315k▲ 6.6%
2024 · €295k
2018: €151k
2019: €190k
2020: €209k
2021: €237k
2022: €250k
2023: €283k
2024: €295k
2018 → 2025
Net result
€58k▲ 15.5%
2024 · €50k
2018: €4k
2019: €28k
2020: €30k
2021: €22k
2022: €8k
2023: €23k
2024: €50k
2018 → 2025
Working capital
€81k▼ 43.6%
2024 · €144k
2018: €-14k
2019: €11k
2020: €39k
2021: €61k
2022: €70k
2023: €94k
2024: €144k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€66k-€73k▲ 11.5%€96k▲ 31.1%€146k▲ 52.5%€85k▼ 42.2%
Operating result€27k-€13k▼ 52.2%€36k▲ 174%€66k▲ 84.8%€72k▲ 8.8%
Net result€22k-€8k▼ 65.2%€23k▲ 202%€50k▲ 121%€58k▲ 15.5%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 9% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €315k
Fixed assets
€3k▲ 51.1%
Current assets
€312k▲ 6.3%
Equity and liabilities €315k
Equity
€85k▼ 42.2%
Debt
€230k▲ 54.5%
The debt ratio rises from 50.4% to 73.1%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€74k▲
2024 · €68k
Cash flow
€60k▲
2024 · €52k
Solvency
26.9%▼
2024 · 49.6%
Current ratio
1.35▼
2024 · 1.97
Quick ratio
0.79▼
2024 · 1.04
Debt / equity
2.72▲
2024 · 1.02
ROE
68.8%▲
2024 · 34.4%
ROA
18.5%▲
2024 · 17.1%
Interest coverage
49.83▲
2024 · 11.13
Debt
€230k▲
2024 · €149k
Debt ≤ 1 year
€230k▲
2024 · €149k
Income taxes
€17k▲
2024 · €15k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€295k€315k▲
Fixed assets21/28€2k€3k▲
Tangible fixed assets22/27€2k€3k▲
Plant, machinery and equipment23€1k€530▼
Furniture and vehicles24€907€3k▲
Current assets29/58€293k€312k▲
Stocks and contracts in progress3€139k€129k▼
Stocks30/36€139k€129k▼
Amounts receivable within one year40/41€137k€168k▲
Trade receivables40€5k€49k▲
Other amounts receivable41€131k€119k▼
Cash at bank and in hand54/58€18k€14k▼
Deferred charges and accrued income490/1€0€872▲
Equity and liabilities
Total equity and liabilities10/49€295k€315k▲
Equity10/15€146k€85k▼
Contributions10/11€30k€30k=
Reserves13€116k€55k▼
Distributable reserves133€116k€55k▼
Profit (loss) carried forward14-€0
Amounts payable17/49€149k€230k▲
Amounts payable within one year42/48€149k€230k▲
Trade debts44€24k€26k▲
Suppliers440/4€24k€26k▲
Taxes, remuneration and social security45€13k€15k▲
Taxes450/3€13k€15k▲
Other amounts payable47/48€112k€189k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€2k▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€8k€7k▼
Other operating charges640/8€513€574▲
Gross operating margin9900€76k€81k▲
Operating profit (loss)9901€66k€72k▲
Financial income75/76B€5k€5k▼
Recurring financial income75€5k€5k▼
Financial charges65/66B€6k€1k▼
Recurring financial charges65€6k€1k▼
Profit (loss) for the period before taxes9903€65k€75k▲
Income taxes67/77€15k€17k▲
Profit (loss) for the period9904€50k€58k▲
Profit (loss) for the period to be appropriated9905€50k€58k▲
Appropriation of the result
Profit (loss) to be appropriated9906€50k€58k▲
Transfer from equity791/2-€65k
Transfer to equity691/2€50k€3k▼
To other reserves6921€50k€3k▼
Profit to be distributed694/7-€120k
Return on contributions (dividend)694-€100k
Directors or managers695-€20k
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2018net €58k ▲15.5%
Operating result €72k, net result €58k, both a record.
29-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €100kEq €146k ▲52.5%
7 profitable years in a row build equity to €146k.
17-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
24-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
26-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
09-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
23-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
16-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 16 days late
2018
29-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
29-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Alveringem · 1 establishment unit since 2007
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Izenbergestraat 578691 AlveringemGround area
2,079 m²
Building footprint
323 m²
Volume, LiDAR
1,836 m³
Parcel 38015A0124/00C000, Flanders · tallest building 8.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK PYLYSER SOFIE
since 20072.166.179.056
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 38015A0124/00C000 | Flanders | 2,079 m² | 1 · 323 m² | 8.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteAlveringem2.166.179.056
Similar companies · same sector, comparable size
MANAGEMENT LORMANS-BEKKERS
BE 0679.571.013
Beringen · Eq €85k
PPPharmacy
BE 0765.736.905
Gent · Eq €85k
BAYART HENSIES
BE 0802.793.378
Dour · Eq €85k
Smart Pharma
BE 0588.980.436
Elsene · Eq €84k
PHARMACIE DELAUNOY
BE 1008.127.037
Sint-Jans-Molenbeek · Eq €85k
Of 5,208 companies in sector 47730 we hold annual accounts for 3,850. 3,288 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-03-2007
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.